NexgenRx (NXG) Price & Analysis

19 Followers

NXG Stock Chart & Stats

C$0.60

-C$0.01(-1.43%)

At close: Jul 27 4:00 PM EDT

C$0.60

-C$0.01(-1.43%)

Day’s Range― - ―

52-Week RangeC$0.29 - C$0.75

Previous CloseN/A

Volume33.56K

Average Volume (3M)12.23K

Market Cap

C$45.16M

Enterprise Value-C$830.36K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)19.1

Beta0.72

Next Earnings

Nov 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.54%

Share Statistics

EPS (TTM)0.01

Shares Outstanding71,117,134

10 Day Avg. Volume8,166

30 Day Avg. Volume12,233

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

NexgenRx News

NexgenRx Delivers Strong Q2 Growth and Declares Dividend

The latest announcement is out from NexgenRx ( ($TSE:NXG) ). NexgenRx Inc. reported a strong second quarter for...

2M ago

NexgenRx Boosts 2025 Profit and Revenue as Cash Remains Strong

The latest announcement is out from NexgenRx ( ($TSE:NXG) ). NexgenRx Inc. reported strong 2025 year-end results, with...

7M ago

NexgenRx Declares Dividends for Shareholders

NexgenRx ( ($TSE:NXG) ) has provided an announcement. NexgenRx has announced a dividend of $0.005 per share for...

10M ago

NexgenRx Reports Strong Q3 2025 Financial Growth

NexgenRx ( ($TSE:NXG) ) just unveiled an announcement. NexgenRx reported significant financial growth in the third quarter of...

11M ago

NexgenRx Declares Dividend, Enhancing Shareholder Value

NexgenRx ( ($TSE:NXG) ) has provided an update. NexgenRx has announced a dividend of $0.005 per share for...

1y ago

NexgenRx Reports Strong Q2 Growth and New Client Acquisition

NexgenRx ( ($TSE:NXG) ) just unveiled an announcement. NexgenRx has reported significant financial growth in the second quarter...

1y ago

NexgenRx Reports Strong Q1 2025 Financial Results and Platform Enhancements

NexgenRx ( ($TSE:NXG) ) has issued an update. NexgenRx has reported a strong financial performance for the first...

1y ago

NexgenRx Declares Dividend, Reinforcing Shareholder Value

NexgenRx ( ($TSE:NXG) ) has issued an announcement. NexgenRx Inc. has declared a dividend of $0.005 per share...

1y ago

NexgenRx Reports Strong 2024 Financial Results and Plans for Market Expansion

NexgenRx ( ($TSE:NXG) ) has shared an announcement. NexgenRx reported strong financial results for 2024, with a 19%...

2y ago

NexgenRx Welcomes Charles Burns Back to Board

NexgenRx (TSE:NXG) has released an update. NexgenRx, a Canadian full-service Third-Party Administrator of health benefits, has announced the...

2y ago

NXG

NXG FAQ

What was NexgenRx Inc’s price range in the past 12 months?

NexgenRx Inc lowest stock price was C$0.29 and its highest was C$0.75 in the past 12 months.

What is NexgenRx Inc’s market cap?

NexgenRx Inc’s market cap is C$45.16M.

When is NexgenRx Inc’s upcoming earnings report date?

NexgenRx Inc’s upcoming earnings report date is Nov 19, 2026 which is in 37 days.

How were NexgenRx Inc’s earnings last quarter?

NexgenRx Inc released its earnings results on Aug 20, 2026. The company reported C$0.013 earnings per share for the quarter.

Is NexgenRx Inc overvalued?

According to Wall Street analysts NexgenRx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NexgenRx Inc pay dividends?

NexgenRx Inc pays a Quarterly dividend of C$0.005 which represents an annual dividend yield of 2.54%. See more information on NexgenRx Inc dividends here

What is NexgenRx Inc’s EPS estimate?

NexgenRx Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NexgenRx Inc have?

NexgenRx Inc has 71,117,134 shares outstanding.

What happened to NexgenRx Inc’s price movement after its last earnings report?

NexgenRx Inc reported an EPS of C$0.013 in its last earnings report. Following the earnings report the stock price went down -6.838%.

Which hedge fund is a major shareholder of NexgenRx Inc?

Currently, no hedge funds are holding shares in TSE:NXG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NexgenRx Inc

NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company was founded by Ronald Campbell Loucks in 2003 and is headquartered in Toronto, Canada.